Literature DB >> 23658444

Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection.

Subhajit Biswas1, Daniel Candotti, Jean-Pierre Allain.   

Abstract

Occult hepatitis B virus (HBV) infection (OBI) is defined as low plasma level of HBV DNA with undetectable HBV surface antigen (HBsAg) outside the preseroconversion window period. The mechanisms leading to OBI remain largely unknown. The potential role of specific amino acid substitutions in the S protein from OBI in HBsAg production and excretion was examined in vitro. HBsAg was quantified in culture supernatants and cell extracts of HuH-7 cells transiently transfected with plasmids containing the S gene of eight HBsAg(+) controls and 18 OBI clones. The intracellular (IC)/extracellular (EC) HBsAg production ratio was ∼1.0 for the majority of controls. Three IC/EC HBsAg patterns were observed in OBI strains clones: pattern 1, an IC/EC ratio of 1.0, was found in 5/18 OBI clones, pattern 2, detectable IC but low or undetectable EC HBsAg (IC/EC, 7.0 to 800), was found in 6/18 OBIs, and pattern 3, low or undetectable IC and EC HBsAg, was found in 7/18 clones. Intracellular immunofluorescence staining showed that in pattern 2, HBsAg was concentrated around the nucleus, suggesting retention in the endoplasmic reticulum. The substitution M75T, Y100S, or P178R was present in 4/6 pattern 2 OBI clones. Site-directed-mutagenesis-corrected mutations reversed HBsAg excretion to pattern 1 and, when introduced into a control clone, induced pattern 2 except for Y100S. In a control and several OBIs, variants of a given quasispecies expressed HBsAg according to different patterns. However, the P178R substitution present in all cloned sequences of two OBI strains may contribute significantly to the OBI phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23658444      PMCID: PMC3700177          DOI: 10.1128/JVI.00710-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma.

Authors:  Teresa Pollicino; Giuseppina Raffa; Lucy Costantino; Antonella Lisa; Cesare Campello; Giovanni Squadrito; Massimo Levrero; Giovanni Raimondo
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

Authors:  Daniel Candotti; C Kit Lin; Dalila Belkhiri; Tasanee Sakuldamrongpanich; Subhajit Biswas; Sujen Lin; Diana Teo; Yasmin Ayob; Jean-Pierre Allain
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

3.  Prediction of transmembrane segments in proteins utilising multiple sequence alignments.

Authors:  B Persson; P Argos
Journal:  J Mol Biol       Date:  1994-03-25       Impact factor: 5.469

4.  A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis.

Authors:  T Kalinina; A Riu; L Fischer; H Will; M Sterneck
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors.

Authors:  Cheng-Hao Huang; Quan Yuan; Pei-Jer Chen; Ya-Li Zhang; Chang-Rong Chen; Qing-Bing Zheng; Shiou-Hwei Yeh; Hai Yu; Yu Xue; Yi-Xin Chen; Ping-Guo Liu; Sheng-Xiang Ge; Jun Zhang; Ning-Shao Xia
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

6.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

Authors:  F V Chisari; K Klopchin; T Moriyama; C Pasquinelli; H A Dunsford; S Sell; C A Pinkert; R L Brinster; R D Palmiter
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.

Authors:  Pong Kian Chua; Robert Yung-Liang Wang; Min-Hui Lin; Tetsuya Masuda; Fat-Moon Suk; Chiaho Shih
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene.

Authors:  Nasser Khan; Michael Guarnieri; Sang Hoon Ahn; Jisu Li; Yonghong Zhou; Genie Bang; Kyun-Hwan Kim; Jack R Wands; Shuping Tong
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.

Authors:  Cristina Gutiérrez; Marisol Devesa; Carmen Luisa Loureiro; Graciela León; Ferdinando Liprandi; Flor Helene Pujol
Journal:  J Med Virol       Date:  2004-06       Impact factor: 2.327

View more
  18 in total

Review 1.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

2.  Recent and occult hepatitis B virus infections among blood donors in the United States.

Authors:  Sumathi Ramachandran; Jamel A Groves; Guo-Liang Xia; Paula Saá; Edward P Notari; Jan Drobeniuc; Amanda Poe; Natasha Khudyakov; Sarah F Schillie; Trudy V Murphy; Saleem Kamili; Chong-Gee Teo; Roger Y Dodd; Yury E Khudyakov; Susan L Stramer
Journal:  Transfusion       Date:  2018-11-30       Impact factor: 3.157

3.  Non-structural protein 1 (NS1) variants from dengue virus clinical samples revealed mutations that influence NS1 production and secretion.

Authors:  Anisa Ghosh; Soumi Sukla; Himadri Nath; Rajdeep Saha; Abhishek De; Subhajit Biswas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-04-09       Impact factor: 5.103

4.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

5.  Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing.

Authors:  Xuelian Deng; Xiaohan Guo; Tingting Li; Syria Laperche; Liang Zang; Daniel Candotti
Journal:  Blood Transfus       Date:  2020-12-17       Impact factor: 3.443

6.  Occult Hepatitis B Virus Infection among β-Thalassemia Major Patients in Ahvaz City, Iran.

Authors:  Fatemeh Amirhashchi; Azarakhsh Azaran; Seyed Saeid Seyedian; Shahram Jalilian; Bijan Keikhaei
Journal:  Am J Trop Med Hyg       Date:  2021-10-04       Impact factor: 3.707

Review 7.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

8.  Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.

Authors:  Jianhong Chen; Yan Liu; Jun Zhao; Zhihui Xu; Rongjuan Chen; Lanlan Si; Shanshan Lu; Xiaodong Li; Shuai Wang; Kai Zhang; Jin Li; Juqiang Han; Dongping Xu
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

10.  Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study.

Authors:  Abhishek De; Subrata Roy; Soumi Sukla; Asad Ansari; Subhajit Biswas
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.